Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Study: An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
The STEP 1 trial (published in the New England Journal of Medicine) documented mean weight reductions of 14.9% with once-weekly semaglutide 2.4 mg compared to 2.4% with placebo, with corresponding improvements in waist circumference of approximately 13.5 cm with semaglutide versus 4.1 cm with placebo after 68 weeks
Drugs like semaglutide and tirzepatide, sold as Ozempic, Wegovy, Mounjaro, and Zepbound, have been studied exhaustively for what they do to blood sugar, appetite, and weight
Compounded medications, including compounded semaglutide, are not FDA-approved and may be prescribed only when a licensed provider determines a clinically significant difference for an identified patient
Contact The Beverly Hills MedSpa today to book your comprehensive clinical consultation and take the first step toward your flawless transformation
US$ 22.73
US$ 28.86
US$ 27.46
US$ 25.89
